FDA drug division chief Tracy Beth Høeg expected to depart amid leadership shakeup

Tracy Beth Høeg, who leads the FDA’s Center for Drug Evaluation and Research, is reported to be leaving the agency.

Her exit comes shortly after former Commissioner Marty Makary stepped down, suggesting a wider turnover among top FDA officials.

Høeg has been noted for her skeptical views on vaccines and antidepressants, and her departure adds another layer of uncertainty to the agency’s drug-approval landscape.